These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 2247528)

  • 21. Properties of glucocorticoid receptors in Epstein-Barr virus-transformed lymphocytes from patients with familial cortisol resistance.
    Iida S; Gomi M; Moriwaki K; Fujii H; Tsugawa M; Tarui S
    Cancer Res; 1989 Apr; 49(8 Suppl):2214s-2216s. PubMed ID: 2539255
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Possible use of glucocorticoid receptor antagonists in the treatment of major depression: preliminary results using RU 486.
    Murphy BE; Filipini D; Ghadirian AM
    J Psychiatry Neurosci; 1993 Nov; 18(5):209-13. PubMed ID: 8297920
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute cortisol administration increases sleep depth and growth hormone release in patients with major depression.
    Schmid DA; Brunner H; Lauer CJ; Uhr M; Yassouridis A; Holsboer F; Friess E
    J Psychiatr Res; 2008 Oct; 42(12):991-9. PubMed ID: 18226817
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma levels of cortisol, corticotropin, and beta-endorphin in patients with major depression.
    Lin SC; Maruta T; Newman DC; Kao PC
    J Clin Psychiatry; 1986 Aug; 47(8):413-4. PubMed ID: 3015893
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of in vivo and in vitro glucocorticoid sensitivity in depression: relationship to the dexamethasone suppression test.
    Lowy MT; Reder AT; Gormley GJ; Meltzer HY
    Biol Psychiatry; 1988 Oct; 24(6):619-30. PubMed ID: 3262379
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cell-mediated immunity and its glucocorticoid-sensitivity after clinical recovery from severe major depressive disorder.
    Wodarz N; Rupprecht R; Kornhuber J; Schmitz B; Wild K; Riederer P
    J Affect Disord; 1992 May; 25(1):31-8. PubMed ID: 1320638
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo and in vitro effects of glucocorticoids on lymphocyte proliferation in depression.
    Rupprecht R; Wodarz N; Kornhuber J; Wild K; Schmitz B; Braner HU; Müller OA; Riederer P; Beckmann H
    Eur Arch Psychiatry Clin Neurosci; 1991; 241(1):35-40. PubMed ID: 1653618
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cortisol resistance in acquired immunodeficiency syndrome.
    Norbiato G; Bevilacqua M; Vago T; Baldi G; Chebat E; Bertora P; Moroni M; Galli M; Oldenburg N
    J Clin Endocrinol Metab; 1992 Mar; 74(3):608-13. PubMed ID: 1740494
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lymphocyte glucocorticoid receptor binding during depression and after clinical recovery.
    Rupprecht R; Kornhuber J; Wodarz N; Lugauer J; Göbel C; Riederer P; Beckmann H
    J Affect Disord; 1991; 22(1-2):31-5. PubMed ID: 1652603
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lymphocyte glucocorticoid receptor binding in depression: normal values following recovery.
    Hunter R; Dick H; Christie JE; Goodwin GM; Fink G
    J Affect Disord; 1988; 14(2):155-9. PubMed ID: 2966829
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Normal lymphocyte responsiveness to lectins but impaired sensitivity to in vitro glucocorticoids in major depression.
    Wodarz N; Rupprecht R; Kornhuber J; Schmitz B; Wild K; Braner HU; Riederer P
    J Affect Disord; 1991 Aug; 22(4):241-8. PubMed ID: 1658104
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lymphocyte sensitivity to glucocorticoids.
    Ganguli R; Robin B
    Am J Psychiatry; 1985 Aug; 142(8):989-90. PubMed ID: 4025603
    [No Abstract]   [Full Text] [Related]  

  • 33. Dexamethasone for depression.
    Wolkowitz OM; Reus VI; Manfredi F; Chan T; Ormiston S; Johnson R
    Am J Psychiatry; 1996 Aug; 153(8):1112; author reply 1112-3. PubMed ID: 8678190
    [No Abstract]   [Full Text] [Related]  

  • 34. Resistance to glucocorticosteroid therapy in inflammatory bowel disease.
    Florin TH
    J Gastroenterol Hepatol; 2003 Jun; 18(6):613-5. PubMed ID: 12753141
    [No Abstract]   [Full Text] [Related]  

  • 35. Depression, cortisol, and immune function.
    Kronfol Z; House JD
    Lancet; 1984 May; 1(8384):1026-7. PubMed ID: 6143959
    [No Abstract]   [Full Text] [Related]  

  • 36. [Primary resistance to cortisol, determined by a disorder of glucocorticoid reception].
    Bezverkhaia TP; Markov VV
    Probl Endokrinol (Mosk); 1991; 37(3):61-5. PubMed ID: 1946300
    [No Abstract]   [Full Text] [Related]  

  • 37. Blunted Cortisol Stress Response and Depression-Induced Hypocortisolism Is Related to Inflammation in Patients With CAD.
    Waller C; Bauersachs J; Hoppmann U; Höch J; Krause S; Szabo F; Engler H; Rottler E; Herrmann-Lingen C; Gündel H
    J Am Coll Cardiol; 2016 Mar; 67(9):1124-1126. PubMed ID: 26940935
    [No Abstract]   [Full Text] [Related]  

  • 38. New glucocorticoids. Mechanisms of immunological activity at the cellular level and in the clinical setting.
    Scudeletti M; Castagnetta L; Imbimbo B; Puppo F; Pierri I; Indiveri F
    Ann N Y Acad Sci; 1990; 595():368-82. PubMed ID: 1695828
    [No Abstract]   [Full Text] [Related]  

  • 39. The effect of amphetamine on plasma cortisol in patients with endogenous and non-endogenous depression.
    Feinberg M; Greden JF; Carroll BJ
    Psychoneuroendocrinology; 1981 Dec; 6(4):355-7. PubMed ID: 7323254
    [No Abstract]   [Full Text] [Related]  

  • 40. Glucocorticoid receptors in depression.
    Harris B; Thomas R
    Br Med J (Clin Res Ed); 1986 May; 292(6531):1334-5. PubMed ID: 3085835
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.